Skip to main content

UBS Group AG

Position in GLMD — Galmed Pharmaceuticals Ltd.

CIK 1610520 ZURICH, V8

Position in GLMD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1
-$1,245 QoQ
Shares Held
3
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 13 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GLMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. GLMD ranks #553 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GLMD

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1 3
2026-03-31 $1,246 2,546
2025-12-31 $1,362 1,814
2025-09-30 $1,328 963
2025-06-30 $12,701 6,903
2025-03-31 $1,589 1,104
2024-12-31 $21,439 6,721
2024-09-30 $36,131 5,267
2024-06-30 $76 280
2024-03-31 $781 2,260
2023-09-30 $17 28
2023-06-30 $2 1
2023-03-31 $1,839 4,307
2022-12-31 $10,716 21,432
2022-09-30 $8,392 26,986
2022-06-30 $3,941 6,064
2021-12-31 $11,567 6,356
2021-09-30 $446 160
2021-03-31 $11,723 3,418
2020-12-31 $32,060 10,309
2020-06-30 $3,025 633
2020-03-31 $12,110 3,500